Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1939 1
1941 2
1950 1
1954 1
1957 1
1958 1
1960 3
1961 2
1962 6
1963 2
1964 4
1965 3
1966 1
1967 3
1968 1
1969 4
1970 6
1971 6
1972 2
1973 11
1974 7
1975 10
1976 15
1977 12
1978 24
1979 20
1980 22
1981 24
1982 36
1983 55
1984 66
1985 96
1986 121
1987 131
1988 164
1989 227
1990 249
1991 307
1992 374
1993 388
1994 464
1995 505
1996 543
1997 469
1998 495
1999 621
2000 659
2001 857
2002 1015
2003 1172
2004 1478
2005 1985
2006 2342
2007 2474
2008 2861
2009 3218
2010 3751
2011 4213
2012 4877
2013 5667
2014 6468
2015 7146
2016 7436
2017 8218
2018 9436
2019 10316
2020 11393
2021 12651
2022 13967
2023 13261
2024 14672
2025 16509
2026 1468

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156,485 results

Results by year

Filters applied: . Clear all
Page 1
B Cell Development and Maturation.
Wang Y, Liu J, Burrows PD, Wang JY. Wang Y, et al. Adv Exp Med Biol. 2020;1254:1-22. doi: 10.1007/978-981-15-3532-1_1. Adv Exp Med Biol. 2020. PMID: 32323265 Review.
A number of B cell subpopulations, including B-1, B-2 and regulatory B cells, have been identified. B-1 cells mainly originate from the fetal liver and contain B-1a and B-1b subsets. B-2 cells are derived from the bone marro …
A number of B cell subpopulations, including B-1, B-2 and regulatory B cells, have been identified. B-1 c …
B Cell Lymphoma.
Meng X, Min Q, Wang JY. Meng X, et al. Adv Exp Med Biol. 2020;1254:161-181. doi: 10.1007/978-981-15-3532-1_12. Adv Exp Med Biol. 2020. PMID: 32323276 Review.
Abnormalities in these genetic events can cause chromosomal translocations and genomic mutations, leading to altered expression and function of genes involved in B cell survival or proliferation and consequently B lymphomagenesis. In fact, B cell lymphoma acc …
Abnormalities in these genetic events can cause chromosomal translocations and genomic mutations, leading to altered expression and function …
Editorial: Insights into Regulatory B Cells.
Wang L, Xu D, Chu Y. Wang L, et al. Front Immunol. 2022 Apr 25;13:903711. doi: 10.3389/fimmu.2022.903711. eCollection 2022. Front Immunol. 2022. PMID: 35547742 Free PMC article. No abstract available.
Does Vitamin B(12) Delay CKD Progression?
Wang AY. Wang AY. Am J Kidney Dis. 2020 Mar;75(3):317-319. doi: 10.1053/j.ajkd.2019.10.003. Epub 2019 Dec 19. Am J Kidney Dis. 2020. PMID: 31866227 No abstract available.
Primary Antibody Deficiencies.
Min Q, Meng X, Wang JY. Min Q, et al. Adv Exp Med Biol. 2020;1254:117-144. doi: 10.1007/978-981-15-3532-1_10. Adv Exp Med Biol. 2020. PMID: 32323274 Review.
Primary antibody deficiencies (PADs) are the most common types of inherited primary immunodeficiency diseases (PIDs) presenting at any age, with a broad spectrum of clinical manifestations including susceptibility to infections, autoimmunity and cancer. Antibodies are produced by …
Primary antibody deficiencies (PADs) are the most common types of inherited primary immunodeficiency diseases (PIDs) presenting at any age, …
HDAC inhibitors overcome immunotherapy resistance in B-cell lymphoma.
Wang X, Waschke BC, Woolaver RA, Chen SMY, Chen Z, Wang JH. Wang X, et al. Protein Cell. 2020 Jul;11(7):472-482. doi: 10.1007/s13238-020-00694-x. Epub 2020 Mar 11. Protein Cell. 2020. PMID: 32162275 Free PMC article. Review.
Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunotherapy resistance is a major challenge for B-cell lymphoma treatment. ...Here, we discuss the possible mechanisms by which B-cell …
Immunotherapy has been applied successfully to treat B-cell lymphomas in preclinical models or clinical settings. However, immunother …
Phenotypic alterations in peripheral blood B Lymphocytes of patients with Alzheimer's Disease.
Wang MT, Wang YR, Zeng GH, Zeng XQ, Fei ZC, Chen J, Zhou J, Li XP, Xu ZQ, Wang YJ, Liu YH. Wang MT, et al. J Prev Alzheimers Dis. 2025 Aug;12(7):100135. doi: 10.1016/j.tjpad.2025.100135. Epub 2025 Mar 21. J Prev Alzheimers Dis. 2025. PMID: 40121165 Free PMC article.
RESULTS: The phenotype of B lymphocytes is altered in AD patients. AD patients exhibit a decrease in both the numbers and proportions of switched memory (SwM) B cells and double-negative (DN) B cells. ...DISCUSSION: This study reveals an altered B-lymp …
RESULTS: The phenotype of B lymphocytes is altered in AD patients. AD patients exhibit a decrease in both the numbers and proportions …
156,485 results
You have reached the last available page of results. Please see the User Guide for more information.